MGMarios A. Gavrielides

Marios A. Gavrielides

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marios A. Gavrielides has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Nicholas Petrick

    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, RM 4126, Silver Spring, MD

    6 shared publications
  • Kyle J. Myers

    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, RM 4126, Silver Spring, MD

    5 shared publications
  • Rongping Zeng

    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, RM 4126, Silver Spring, MD

    5 shared publications
  • Berkman Sahiner

    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, RM 4126, Silver Spring, MD

    4 shared publications
  • Qin Li

    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Building 62, RM 4126, Silver Spring, MD

    4 shared publications
  • Nicholas Petrick

    U.S. Food and Drug Administration

    3 shared publications

Latest Publications

  • Clinical Decision Support for Ovarian Carcinoma Subtype Classification: A Pilot Observer Study With Pathology Trainees

    by Marios A. Gavrielides, Meghan Miller, Ian S. Hagemann, Heba Abdelal, Zahra Alipour, Jie-Fu Chen, Behzad Salari, Lulu Sun, Huifang Zhou, Jeffrey D . Seidman

    Context.—: Clinical decision support (CDS) systems could assist less experienced pathologists with certain diagnostic tasks for which subspecialty training or extensive experience is typically needed. The effect of decision support on pathologist performance for such diagnostic tasks has not been examined. Objective.—: To examine the impact of a CDS tool for the classification of ovarian carcinoma subtypes by pathology trainees in a pilot observer study using digital pathology. Design.—: Histologic review on 90 whole slide images from 75 ovarian cancer patients was conducted by 6 pathology residents using: (1) unaided review of whole slide images, and (2) aided review, where in addition to whole slide images observers used a CDS tool that provided information about the presence of 8 histologic features important for subtype classification that were identified previously by an expert in gynecologic pathology. The reference standard of ovarian subtype consisted of majority consensus from a panel of 3 gynecologic pathology experts. Results.—: Aided review improved pairwise concordance with the reference standard for 5 of 6 observers by 3.3% to 17.8% (for 2 observers, increase was statistically significant) and mean interobserver agreement by 9.2% (not statistically significant). Observers benefited the most when the CDS tool prompted them to look for missed histologic features that were definitive for a certain subtype. Observer performance varied widely across cases with unanimous and nonunanimous reference classification, supporting the need for balancing data sets in terms of case difficulty. Conclusions.—: Findings showed the potential of CDS systems to close the knowledge gap between pathologists for complex diagnostic tasks.


  • Discrimination of Pulmonary Nodule Volume Change for Low- and High-contrast Tasks in a Phantom CT Study with Low-dose Protocols

    by Marios A. Gavrielides, Qin Li, Rongping Zeng, Benjamin Paul Berman, Berkman Sahiner, Qi Gong, Kyle J. Myers, Gino DeFilippo, Nicholas Petrick


  • Quantitative assessment of nonsolid pulmonary nodule volume with computed tomography in a phantom study

    by Marios A. Gavrielides, Benjamin P. Berman, Mark Supanich, Kurt Schultz, Qin Li, Nicholas Petrick, Rongping Zeng, Jenifer Siegelman

    Background: To assess the volumetric measurement of small (≤1 cm) nonsolid nodules with computed tomography (CT), focusing on the interaction of state of the art iterative reconstruction (IR) methods and dose with nodule densities, sizes, and shapes. Methods: Twelve synthetic nodules [5 and 10 mm in diameter, densities of −800, −630 and −10 Hounsfield units (HU), spherical and spiculated shapes] were scanned within an anthropomorphic phantom. Dose [computed tomography scan dose index (CTDIvol)] ranged from standard (4.1 mGy) to below screening levels (0.3 mGy). Data was reconstructed using filtered back-projection and two state-of-the-art IR methods (adaptive and model-based). Measurements were extracted with a previously validated matched filter-based estimator. Analysis of accuracy and precision was based on evaluation of percent bias (PB) and the repeatability coefficient (RC) respectively. Results: Density had the most important effect on measurement error followed by the interaction of density with nodule size. The nonsolid −630 HU nodules had high accuracy and precision at levels comparable to solid (−10 HU) nonsolid, regardless of reconstruction method and with CTDIvol as low as 0.6 mGy. PB was Conclusions: Reasonable values of both accuracy and precision were achieved for volumetric measurements of all 10-mm nonsolid nodules, and for the 5-mm nodules with −630 HU or higher density, when derived from scans acquired with below screening dose levels as low as 0.6 mGy and regardless of reconstruction algorithm.


  • Volume estimation of multidensity nodules with thoracic computed tomography

    by Marios A. Gavrielides, Qin Li, Rongping Zeng, Kyle J. Myers, Berkman Sahiner, Nicholas Petrick

    This work focuses on volume estimation of “multidensity” lung nodules in a phantom computed tomography study. Eight objects were manufactured by enclosing spherical cores within larger spheres of double the diameter but with a different density. Different combinations of outer-shell/inner-core diameters and densities were created. The nodules were placed within an anthropomorphic phantom and scanned with various acquisition and reconstruction parameters. The volumes of the entire multidensity object as well as the inner core of the object were estimated using a model-based volume estimator. Results showed percent volume bias across all nodules and imaging protocols with slice thicknesses <5  mm ranging from −5.1% to 6.6% for the entire object (standard deviation ranged from 1.5% to 7.6%), and within −12.6% to 5.7% for the inner-core measurement (standard deviation ranged from 2.0% to 17.7%). Overall, the estimation error was larger for the inner-core measurements, which was expected due to the smaller size of the core. Reconstructed slice thickness was found to substantially affect volumetric error for both tasks; exposure and reconstruction kernel were not. These findings provide information for understanding uncertainty in volumetry of nodules that include multiple densities such as ground glass opacities with a solid component.


  • Open Access

    Observer Performance in the Use of Digital and Optical Microscopy for the Interpretation of Tissue-Based Biomarkers

    by Marios A. Gavrielides, Catherine Conway, Neil O’flaherty, Brandon D. Gallas, Stephen M. Hewitt

    Background.We conducted a validation study of digital pathology for the quantitative assessment of tissue-based biomarkers with immunohistochemistry.Objective.To examine observer agreement as a function of viewing modality (digital versus optical microscopy), whole slide versus tissue microarray (TMA) review, biomarker type (HER2 incorporating membranous staining and Ki-67 with nuclear staining), and data type (continuous and categorical).Methods.Eight pathologists reviewed 50 breast cancer whole slides (25 stained with HER2 and 25 with Ki-67) and 2 TMAs (1 stained with HER2, 1 with Ki-67, each containing 97 cores), using digital and optical microscopy.Results.Results showed relatively high overall interobserver and intermodality agreement, with different patterns specific to biomarker type. For HER2, there was better interobserver agreement for optical compared to digital microscopy for whole slides as well as better interobserver and intermodality agreement for TMAs. For Ki-67, those patterns were not observed.Conclusions.The differences in agreement patterns when examining different biomarkers and different scoring methods and reviewing whole slides compared to TMA stress the need for validation studies focused on specific pathology tasks to eliminate sources of variability that might dilute findings. The statistical uncertainty observed in our analyses calls for adequate sampling for each individual task rather than pooling cases.


  • Minimum Detectable Change in Lung Nodule Volume in a Phantom CT Study

    by Marios A. Gavrielides, Qin Li, Rongping Zeng, Kyle J. Myers, Berkman Sahiner, Nicholas Petrick


  • Benefit of Overlapping Reconstruction for Improving the Quantitative Assessment of CT Lung Nodule Volume

    by Marios A. Gavrielides, Rongping Zeng, Kyle J. Myers, Berkman Sahiner, Nicholas Petrick


  • Open Access

    Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer

    by Tyler Keay, Catherine M Conway, Neil O'Flaherty, Stephen M Hewitt, Katherine Shea, Marios A Gavrielides


  • Statistical Analysis of Reader Measurement Variability in Nodule Sizing with CT Phantom Imaging Data

    by Zhan-Qian John Lu, Charles Fenimore, Nicholas Petrick, Rongping Zeng, Marios A. Gavrielides, David Clunie, Kristin Borradaile, Robert Ford, Hyun J. Grace Kim, Michael F. McNitt-Gray, et al.

  • Quantitative Assessment and Classification of Tissue-Based Biomarker Expression With Color Content Analysis

    by Brad Keller, Weijie Chen, Marios A. Gavrielides

    Context .—The use of computer aids has been suggested as a way to reduce interobserver variability that is known to exist in the interpretation of immunohistochemical staining in pathology. Such computer aids should be automated in their usage but also they should be trained in an automated and reproducible fashion. Objective .—To present a computer aid for the quantitative analysis of tissue-based biomarkers, based on color content analysis. Design .—The developed system incorporates an automated algorithm to allow retraining based on the color properties of different training sets. The algorithm first generates a color palette containing the colors present in a training subset. Based on the palette, color histograms are derived and are used as feature vectors to a pattern recognition system, which returns an output proportional to biomarker continuous expression or a categorical classification. The method was evaluated on a database of HER2/ neu digital breast cancer slides, for which expression scores from a pathologist panel were available. The system was retrained and evaluated on different transformations of the database, including compression, blurring, and changes in illumination, to examine its robustness to different imaging conditions frequently met in digital pathology. Results .—Results showed high agreement between the results of the algorithm and the truth from the pathologist panel as well as robustness to image transformations. Conclusions .—The results of the study are encouraging for the potential of this method as a computer aid to assess biomarker expression in a consistent and reproducible manner.